Skip to main content

Table 1 Clinical and epidemiological characteristics and outcomes of 19 cases of imported malaria in pregnancy

From: Imported malaria in pregnancy in Madrid

Variables

Frequency

(%)

Country of Origin

   
 

Equatorial Guinea

11

(57.9)

 

Nigeria

6

(31.6)

 

Congo

1

(5.3)

 

Ghana

1

(5.3)

Mean Age Years (+/- SD)

 

27

(+/-5.3)

Reason for Travel

   
 

VFR

17

(89.5)

 

National Traveller

0

 

Recent Immigration

Yes

2

(10.5)

Chemoprophylaxis

   
 

None/Incorrect/Incomplete

19

(100)

Co-morbidities

   
 

None

11

(57.9)

 

HIV

3

(15.8)

 

Hypertension

1

(5.3)

 

Smoker

1

(5.3)

 

Other

3

(15.8)

Gestational Age

   
 

Third Trimester

10

(52.6)

 

Second Trimester

3

(15.8)

 

First Trimester

6

(31.6)

Parity

   
 

Multigravidae

18

(94.7)

 

Primigravidae

1

(5.3)

Classification As High Risk Pregnancy

Yes

6

(31.6)

Clinical Presentation

   
 

-Asymptomatic

3

(15.8)

 

-Symptomatic

16

(84.2)

 

   Fever

14

(73.6)

 

Fever Alone

7

(36.8)

 

Fever + Gastrointestinal

4

(21.1)

 

Fever + Flu-Like Symptoms

3

(15.8)

 

   Other

2

(10.5)

- Signs

   
 

None

17

(89.5)

 

Splenomegaly (At examination and/or ultrasound)

1

(5.3)

 

Hepatosplenomegaly (At examination and/or ultrasound)

1

(5.3)

Laboratory Findings

   
 

-Anaemia (Hb < 11 g/Dl)

15

(78.9)

 

   Mild (9-10.9 g/Dl)

6

(31.6)

 

   Moderate (7-8.9 G/Dl)

6

(31.6)

 

   Severe (Hb < 7 g/Dl)

3

(15.8)

 

-Thrombocytopaenia (< 150,000/Mm3)

14

(73.7)

 

   Mild (100,000-150,000/Mm3)

8

(42.1)

 

   Moderate (80,000-10,000/Mm3)

2

(10.5)

 

   Severe (< 80,000/Mm3)

4

(21.1)

 

-Hypoglycaemia (Serum Glucose < 60 Mg/Dl, With Or Without Symptoms)

2

(10.5)

Microbiology

   
 

- P. falciparum (One Mixed Infection)

19

(100)

 

Parasitaemia > 4%

1

(5.3)

 

Parasitaemia 1-4%

5

(26.3)

 

Parasitaemia < 1%

11

(57.9)

 

No data

2

(26.3)

Diagnostic delay days Median (IR)

 

7.5

(2.7-21.7)

Treatment

   
 

Quinine + Clindamycin

16

(84.2)

 

Mefloquine

1

(5.3)

 

Atovaquone + Proguanil*

2

(10.5)

Maternal outcome

   

- Death

 

0

(0)

-Clinical complications

 

0

(0)

-Anaemia improvement (N = 15)

Yes

9

(60)

 

No data

6

(40)

Foetal outcome

   
 

-Abortion

2

(10.5)

 

-Delivery Term

15

(78.9)

 

No data (Lost to follow-up)

2

(10.5)

-Birth weight N = 15

> 2,500 g

15

(100)

 

< 2,500 g

0

(0)

Parasitological follow-up

   
 

Undetectable parasitaemia

12

(63.2)

 

No data

7

(38.9)

  1. VFR: visiting friends and relatives
  2. SD: standard deviation
  3. IR: interquartile range (25th-75th percentile)
  4. * Two patients received atovaquone-proguanil: one after premature abortion and another after term delivery